Wire Stories

Graphene & Solar Technologies New Shareholder Letter & Update

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech “Thin-Film”…

5 years ago

Graphene & Solar Technologies New Shareholder Letter & Update

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech “Thin-Film”…

5 years ago

Boston Metal Wins S&P Global Platts Global Metals Award

Winners announced in London, UK BOSTON--(BUSINESS WIRE)--Boston Metal won the New Technology for the Metals and Mining Industry award at…

5 years ago

Graphene & Solar Technologies New Shareholder Letter & Update

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech “Thin-Film”…

5 years ago

Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting…

5 years ago

Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting…

5 years ago

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial…

5 years ago

Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting…

5 years ago

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial…

5 years ago

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial…

5 years ago